Serum Institute plans to start production outside India to meet vaccine demand- Report

Serum Institute plans to start production outside India to meet vaccine demand- Report

New Delhi The Serum Institute of India is also planning vaccine production in other countries to fulfill its vaccine supply commitments. The Serum Institute produces the AstraZeneca covid-19 vaccine. In India, it is being constructed in the name of Covishield.

Serum Institute CEO Adar Poonawal said in an interview to Times Newspaper that it could be announced in the next few days. Poonawalla said last week that the Serum Institute would be able to increase its monthly production to 100 million doses by the end of July, while earlier its timeline was set by the end of May. There is a shortage of Covid-19 vaccine in many states of India. Poonawal said that within six months to a year the production capacity of Serum Institute is expected to increase from 2.5 billion to 3 billion doses.

The infrastructure of health services broke due to increasing cases in the country

Corona virus cases and deaths have increased in India as the world’s second most populous country received more than 300,000 new infections cases for nine consecutive days. Whereas on Saturday, today, more than 4 lakh new cases have come. This surge in corona cases has created a public health crisis and the government has been forced to take oxygen, medicines and other essential commodities from abroad.

Corona estimated to reach peak between May 3-5

According to the scientists advising the government, corona virus cases in the country can reach the peak between 3-5 May. Some health experts said that when around 10,000 cases were coming to India daily and the novel Corona virus was under control, the governments loosened the restrictions which led to the resumption of major festivals and political rallies.

Source link